tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Kura Oncology completes first U.S. commercial sale of KOMZIFTI
PremiumThe FlyKura Oncology completes first U.S. commercial sale of KOMZIFTI
1M ago
Kura Oncology’s Growth Potential Boosted by KOMZIFTI’s NCCN Inclusion and Competitive Advantages
Premium
Ratings
Kura Oncology’s Growth Potential Boosted by KOMZIFTI’s NCCN Inclusion and Competitive Advantages
2M ago
Positive Outlook on Kura Oncology: Komzii’s Approval and Safety Profile Drive Buy Rating
Premium
Ratings
Positive Outlook on Kura Oncology: Komzii’s Approval and Safety Profile Drive Buy Rating
2M ago
Kura Oncology price target raised to $16 from $14 at UBS
PremiumThe FlyKura Oncology price target raised to $16 from $14 at UBS
2M ago
Kura Oncology’s Strategic Positioning and FDA Approval of Komzii Boosts Buy Rating
Premium
Ratings
Kura Oncology’s Strategic Positioning and FDA Approval of Komzii Boosts Buy Rating
2M ago
Kura Oncology Gains FDA Approval for KOMZIFTITM
Premium
Company Announcements
Kura Oncology Gains FDA Approval for KOMZIFTITM
2M ago
Kura Oncology reports inducement grants under Nasdaq listing rule
PremiumThe FlyKura Oncology reports inducement grants under Nasdaq listing rule
2M ago
Kura Oncology Advances Precision Cancer Therapies
Premium
Company Announcements
Kura Oncology Advances Precision Cancer Therapies
2M ago
Kura Oncology’s Positive Outlook in Latest Earnings Call
Premium
Company Announcements
Kura Oncology’s Positive Outlook in Latest Earnings Call
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100